Relationship of androgenic alopecia with higher BMI in Pakistan: A cross sectional study
DOI:
https://doi.org/10.66344/jpad.v31i1.1526Keywords:
Androgenetic, Alopecia, BMI, MetabolicAbstract
Objective To determine the relationship of higher basal metabolic index (BMI) with severity of androgenic alopecia.
Methods A hospital-based analytical cross-sectional study was done in men in the age group of 17-55 year. Weight and height were taken to determine BMI and Norwood scale was used to grade AGA.
Results In this cross sectional study a total of 246 participants were included. Majority of them were (69.90%) of 31-40 years. Most of the men (45.10%) were in severe stage (6,7) of alopecia trailed by (43.09%) those having moderate stage (3,4,5). Most of them (62.60%) having AGA were obese (BMI > 30).
Conclusion Patients with severe AGA were significantly and strongly associated with higher BMI.
References
1. Yang CC, Hsieh FN, Lin LY, Hsu CK, Sheu HM, Chen W. Higher body mass index is associated with greater severity of alopecia in men with male-pattern androgenetic alopecia in Taiwan: a cross-sectional study. J Am Acad Dermatol. 2014;70(2):297-302.
2. Elizabeth Y, Katherine LBN, Antonella T. 5α-Reductase inhibitors in androgenetic alopecia. Current Opin Endocrinol Diabetes Obes. 2014;21(6):493-8.
3. Dow Stough, Kurt Stenn, Robert Haber, William M Parsley, James E Vogel, David A Whiting, Ken Washenik. Psychological effect, pathophysiology, and management of androgenetic alopecia in men. Mayo Clin Proc. 2005;80(10):1316-22.
4. Yim E, Nole KL, Tosti A. 5α-Reductase inhibitors in androgenetic alopecia. Curr Opin Endocrinol Diabetes Obes. 2014;21(6):493-8.
5. Gok SO, Belli AA, Dervis E. Is There Really Relationship between Androgenetic Alopecia and Metabolic Syndrome?. Dermatol Res Pract. 2015;1-4.
6. Grover S. A study of patterns of androgenetic alopecia in men: an Indian perspective. Br J Dermatol. 2005;152(3):572-4.
7. Yi SM, Son SW, Lee KG, Kim SH, Lee SK, Cho ER et al. Gender-Specific Association of Androgenetic Alopecia With Metabolic Syndrome in a Middle-aged Korean Population. Br J Dermatol. 2012;167(2):306-13.
8. Hirsso P1, Laakso M, Matilainen V, Hiltunen L, Rajala U, Jokelainen J, et al. Association of insulin resistance linked diseases and hair loss in elderly men. Finnish population-based study. Cent Eur J Public Health. 2006;14(2):78–81.
9. Lotufo PA1, Chae CU, Ajani UA, Hennekens CH, Manson JE. Male pattern baldness and coronary heart disease: the Physicians' Health Study. Arch Intern Med. 2000;160(2):165–71.
10. Nanan D.J. The Obesity Pandemic- Implications for Pakistan. J Pak Med Assoc. 2002;52(8):342-6.
11. Norwood OT. Male pattern baldness: Classification and incidence. South Med J. 1975;68(11):1359–70.
12. Hirsso P1, Laakso M, Matilainen V, Hiltunen L, Rajala U, Jokelainen J, et al. Association of insulin resistance linked diseases and hair loss in elderly men. Finnish population-based study. Cent Eur J Public Health. 2006;14(2):78–81.
13. Matilainen V, Koskela P, Keinanen-Kiukaanniemi S. Early androgenetic alopecia as a marker of insulin resistance. Lancet 2000;356(9236):1165–6.
14. Ahouansou S, Le Toumelin P, Crickx B, Descamps V. Association of androgenetic alopecia and hypertension. Eur J Dermatol 2007;17(3):220–2.
15. Hirsso P1, Rajala U, Hiltunen L, Jokelainen J, Keinänen-Kiukaanniemi S, Näyhä S.. Obesity and low-grade inflammation among young Finnish men with early-onset alopecia. Dermatology 2007;214(2):125–9.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Asif Kamal, Jawaria Farzand Raja
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
